BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 28, 2017
View Archived Issues
AAV-mediated liver delivery of secretable GAA improves long-term survival in Pompe disease mice
Read More
Tasigna receives approval in Japan for treatment of pediatric chronic myeloid leukemia
Read More
SK Chemicals launches SKYZoster shingles vaccine in South Korea
Read More
Pfizer enrolling participants in phase I study of PF-06863135
Read More
Clover Biopharmaceuticals receives approval to initiate clinical trials of SCB-808 in China
Read More
FDA accepts NDA for OTX-101
Read More
Maruho and RaQualia enter worldwide license agreement
Read More
Celgene researchers report compounds with antiprotozoal activity
Read More
Agents for the treatment of malaria described in Celgene patent
Read More
P2X7 receptor antagonists for pain reported in Shionogi patent
Read More
Beijing Jacobio Pharmaceuticals patents SHP-2 inhibitors
Read More
Pramana Pharmaceuticals patent describes glucose-dependent insulinotropic receptor agonists
Read More
Lilly initiates phase II study of LY-3002813 and LY-3202626 in early symptomatic Alzheimer's disease
Read More
Athenex receives U.K. promising innovative medicine designation for Oraxol
Read More
Combination therapy with gedatolisib shows promising preliminary antitumor activity in breast cancer
Read More
Kaiso as a potential new biomarker and therapeutic target in TNBC
Read More
NeuroRx enters agreement for clinical trial of NRX-100/NRX-101 regimen
Read More
Phase II data show safety of combining Ra-223 with hormonal therapy and denosumab
Read More
Phase III SIERRA study of Iomab-B cleared to continue enrollment
Read More
Phase II safety data for abemaciclib as treatment of brain metastases secondary to HR+ breast cancer
Read More
First patient enrolled in phase III OVAL study of VBL Therapeutics' VB-111
Read More
Keytruda approved for new indication in Japan
Read More
Innovation Pharmaceuticals reports preliminary data from phase IIa study of Kevetrin
Read More
Protalix Biotherapeutics' pegunigalsidase alfa granted orphan drug status in E.U.
Read More
New phase III trial explores use of TSC in newly diagnosed GBM
Read More
CFDA designates lenvatinib for priority review and approval for HCC
Read More
Bayer initiates phase III studies in Japan of molidustat in nondialysis patients with renal anemia
Read More
Eli Lilly's Zyprexa approved for chemotherapy-induced nausea and vomiting in Japan
Read More